ARTICLE | Clinical News
Xtandi enzalutamide: Phase II data
February 2, 2015 8:00 AM UTC
Top-line data from the double-blind, international Phase II TERRAIN trial in 375 patients with metastatic prostate cancer whose disease progressed despite treatment with a luteinizing hormone-releasi...